Skip to main content

BMY - Bristol-Myers Squibb Co.

This page shows which of the focused investors we track hold BMY and how their positions changed, so you can see how much conviction the group has in the stock.

In Q4 2022 it was held by 10 managers with an aggregate reported value of $1.62B, which is 0.16% of the combined portfolio.

As of Q4 2022, 10 tracked institutional managers held BMY (Bristol-Myers Squibb Co.) with an aggregate reported value of $1.62B0.16% of the combined AlphaBaseline portfolio.

Get email alerts when a tracked manager trades BMY sign in or create a free account.

Source
Curated SEC 13F filings
Period
Q4 2022
Ticker
BMY

13F data is delayed and excludes shorts/non-13F assets.

Holders

1Dodge & Cox - Dodge & Cox0.82%Reduce -1.4%16,544,344$1.19B
2Richard Pzena - Pzena Investment Management1.23%Reduce -3.3%3,860,572$277.77M
3Kahn Brothers Group - Kahn Brothers Group8.66%Reduce -1.1%914,001$65.76M
4Ariel Investments - Ariel Investments0.58%Reduce -1.2%789,666$56.82M
5Torray Funds - Torray Funds2.09%-161,134$11.59M
6Muhlenkamp - Muhlenkamp3.93%Add +0.1%128,950$9.28M
7Mairs & Power Growth Fund - Mairs & Power Growth Fund0.07%Reduce -0.7%79,107$5.69M
8Jensen Investment Management - Jensen Investment Management0.01%-26,375$1.9M
9David Katz - Matrix Asset Advisors0.07%-6,650$478.47K
10David Rolfe - Wedgewood Partners0.06%Reduce -23.0%4,175$300K
Loading holder history for BMY